CDP Venture Capital
VC Fund
Rome, Italy
CDP Venture Capital is a VC fund in Rome focused on Software and Artificial Intelligence. CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
- Total investments:
- 301
- Last investment:
- Lead investor:
- 41%
- Fund size:
- $212M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries CDP Venture Capital invests in
Stages CDP Venture Capital invests in
Countries CDP Venture Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 13 contacts → | |||
Round size
- Seed
- $483k–$8.1M
- Series A
- $3.3M–$23M
- Venture - Series Unknown
- $652k–$16M
Investment Focus
Industry
- Software 44 (15%)
- Artificial Intelligence 35 (12%)
- Health Care 26 (9%)
- Biotechnology 26 (9%)
- Information Technology 24 (8%)
Stage
- Seed 91 (30%)
- Series A 57 (19%)
- Venture - Series Unknown 38 (13%)
- Pre-Seed 32 (11%)
- Series B 21 (7%)
Country
- Italy 190 (63%)
- United States 9 (3%)
- Switzerland 6 (2%)
- Germany 4 (1%)
- United Kingdom 4 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Emanuele Levi
Chief Executive Officer
|
Chief Executive Officer | Total investments: 5 | Find email | |
Lorenzo Franchini
Senior Partner - Co-Head of the Evolution Fund
|
Senior Partner - Co-Head of the Evolution Fund | Total investments: 2 | Find email | |
Claudia Pingue
Senior Partner
|
Senior Partner | Total investments: 25 | Find email | |
Enrico Fili'
Head of CdP Lab
|
Head of CdP Lab | Total investments: 12 | Find email | |
Filippo Bosco
Senior Investment Manager
|
Senior Investment Manager | Total investments: 1 | Find email | |
| See all 13 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Aptadir Therapeutics is developing RNA inhibitor-based therapeutics for treating intractable cancers and genetic conditions. | $45.5M / Seed / Sep 29, 2026 | ||
| Kubernetes multi-tenancy made easy | $3.3M / Seed / Sep 24, 2026 | ||
| Dialybrid provide product that include silkothane arteriovenous graft, SAG biomimetic nanostructure, and situ tissue engineering products. Their proprietary innovative technology, silkothane, is a hybrid material combining silk fibroin and polyurethane. Their aim is to develop a novel semi-degradable vascular access for hemodialysis. | $17.2M / Series A / Sep 22, 2026 | ||
| Tundr combines technology with environmentally friendly mobility. TundrMove is the first sustainable mobility voucher. A winning combination for improving workplace quality of life while also redefining the concept of green mobility. The ecosystem includes a SmartCard, on which it will be possible to load mobility vouchers and a brand new App toexplore more ecological and sustainable modes of transport and estimate CO2 emissions. | $13.3M / Series A / Sep 21, 2026 | ||
| Ferm Labs ingredient startup specializing in proprietary, high-yield bioprocessing platforms. | $3.5M / Seed / Sep 14, 2026 | ||
| At Circular Materials, we believe that valuable resources should be kept in the value chain and not lost to the environment. Our mission is to extend the lifetime of metals in the value chain and prevent the dispersion of critical raw materials by providing innovative and sustainable technologies. Our goal is to transform linear value chains intocircular ones, providing scalable and cost-effective solutions for black mass recycling and industrial wastewater valorization to recover critical raw materials from waste streams. Our proprietary technologies and processes enable us to efficiently recover elements such as Nickel, Cobalt, Copper, Manganese and Lithium from industrial wastestreams, delivering secondary raw materials with low carbon footprint and high sustainability. We are dedicated to working with companies across various industries to optimize their operations, improve their sustainability profile, and gain a competitive edge in a rapidly evolving raw materials market. We are driven by our belief that a circular economy is not only possible but necessary to reduce waste, minimize reliance on expensive virgin materials, and build a more sustainable future. We are proud to be at the forefront of this movement, and we look forward to working with our partners and stakeholders to drive positive change in the industry and beyond. | $13.5M / Venture - Series Unknown / Jul 21, 2026 | ||
| Talentware is a startup born in 2023 within the venture studio of Bain & Company, from the idea of 3 Bain Alumni to revolutionize the approach to talent management within companies. At Talentware, we specialize in providing an AI-powered SaaS platform to empower companies to engage, develop, and retain their talent using a skill-basedapproach. By analyzing employees' skills, interests, and work preferences, Talentware automatically charts potential career paths and identifies individual skill gaps to suggest personalized development opportunities to each employee. Our goal is to transform static and manual talent processes through the power of AI and deliver continuous skills innovation for a future-ready workforce. | $3.8M / Seed / Jul 21, 2026 | ||
| Klaro is an AI platform that assists small businesses with credit and improves cash flow management. | $3.4M / Seed / Jul 06, 2026 | ||
| Archimede's AI assistant turns natural language into fully working IoT dashboards. Describe the idea, and the system creates a complete satellite-connected application in seconds. | $1.7M / Seed / Jun 29, 2026 | ||
| Salute360 is a digital health company committed to transforming the way patients and healthcare professionals connect and interact. We designed and developed an integrated platform that simplifies access to reliable healthcare information and digital services, compliant to EU Health Regulation and HIPAA. Our mission is to make healthcare moreaccessible, secure, and patient-centered through smart digital solutions. Salute360 empowers healthcare professionals and organizations to deliver more efficient, collaborative, and personalized care - whether in prevention, treatment, or ongoing health management. We support pharmacies, clinics, life science companies, insurance providers, and welfare programs in enhancing their services and creating innovative digital health strategies. At the heart of our work is a connected ecosystem that fosters collaboration and puts the patient at the center of a more intuitive and inclusive healthcare experience. | $579.6K / Seed / Jun 15, 2026 | ||
| See all 301 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does CDP Venture Capital invest in?
CDP Venture Capital invests primarily in Software, Artificial Intelligence and Health Care startups, most often at Seed and Series A stage. Most of the 301 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is CDP Venture Capital's check size?
CDP Venture Capital typically joins rounds of $483k–$8.1M at Seed, $3.3M–$23M at Series A and $652k–$16M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds CDP Venture Capital participates in.
How do I contact CDP Venture Capital?
Public channels for CDP Venture Capital include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CDP Venture Capital?
The team at CDP Venture Capital includes Emanuele Levi (Chief Executive Officer), Lorenzo Franchini (Senior Partner - Co-Head of the Evolution Fund) and Claudia Pingue (Senior Partner), among 13 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
